Regional Differences in Apolipoprotein E Polymorphism in Finland-Reference-Cited by-同舟云学术

Regional Differences in Apolipoprotein E Polymorphism in Finland

Published:1991-01 Issue:1 Volume:23 Page:61-66
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Lehtimäki Terho,Moilanen Teemu,Nikkari Tapio,Solakivi Tiina,Porkka Kimmo,Ehnholm Christian,Rönnemaa Tapani,Åkerblom Hans K.,Uhari Matti,Nuutinen E. Matti,Kaprio Eero A.,Pesonen Erkki,Pietikäinen Matti,Dahl Matti,Salo Matti K.,Viikari Jorma

Publisher

Informa UK Limited

Subject

General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/07853899109147932

Reference34 articles.

1. Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components

2. Plasma lipoproteins: apolipoprotein structure and function.

3. A Receptor-Mediated Pathway for Cholesterol Homeostasis

4. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins.

5. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SNP of HMGCR and Apo E genes and their impact in response to statin therapy in hypercholesterolemic and hypertriglyceridemic patients in Pakistan;PAK J PHARM SCI;2021

2. HMGCR and ApoE mutations may cause different responses to lipid lowering statin therapy;Cellular and Molecular Biology;2017-10-31

3. Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives;Pharmacogenomics;2012-05

4. Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease;Pharmacogenomics;2008-10

5. Differences in the Association Between Apolipoprotein E Genotype and Mortality Across Populations;The Journals of Gerontology Series A: Biological Sciences and Medical Sciences;2007-08-01